# ACETAMINOPHEN
> **ANDA215403** · Abbreviated New Drug Application (Generic) · Sponsor: INFORLIFE · Approved 2023-05-03
## Drug
- **FDA Application Number:** ANDA215403
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACETAMINOPHEN
- **Generic name:** ACETAMINOPHEN
- **Active ingredients:** ACETAMINOPHEN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** INFORLIFE
- **Manufacturer:** WG Critical Care, LLC
- **First approval:** 2023-05-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215403)
---
*MORVS · CC0 1.0*